Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

June 02, 2015 12:49 AM ET

Healthcare Equipment and Supplies

Company Overview of Plasma Technologies, Inc.

Company Overview

Plasma Technologies, Inc., a medical technology company, designs, develops, patents, and markets medical devices for wound healing, tissue regeneration, and sterilization applications. It offers plasma medical devices for the sterilization of live tissue; and blood coagulation, as well as to kill cancer cells; and treat and prevent infections. The company also provides plasma sterilization applications to sterilize air, surfaces, and foods. Its plasma devices are used in hospitals and nursing facilities, clinics, public buildings, and food processing plants, as well as on the battlefield. The company was founded in 2007 and is based in Corpus Christi, Texas.

615 North Upper Broadway

Suite 1950

Corpus Christi, TX 78401

United States

Founded in 2007





Key Executives for Plasma Technologies, Inc.

Vice President of Community and Governmental Relations
Compensation as of Fiscal Year 2014.

Plasma Technologies, Inc. Key Developments

Access Pharmaceuticals Signs Exclusive Global License Agreement with Plasma Technologies for the Development and Commercialization of its Proprietary Plasma Fractionation Process

Access Pharmaceuticals announced that it has signed an exclusive, global license agreement with Plasma Technologies (PlasmaTech) for the development and commercialization of its proprietary plasma fractionation process. Concurrently, the company announced a new corporate management team and its intention to strategically refocus and rebrand the company as PlasmaTech Biopharmaceuticals, Inc.â ¢, and its plans to pursue a national listing for its common shares. Under the terms of the licensing agreement, the company will pay a license fee of $5 million in a combination of cash and common stock subject to the achievement of certain events, including, a regulatory approval milestone payment in common shares upon the first FDA regulatory approval of a drug derived from the PlasmaTech fractionation process, and a tiered royalty on annual net sales of plasma fractions produced with the proprietary fractionation process.

Similar Private Companies By Industry

Company Name Region
Ziehm Imaging Inc. United States
Lifescan Products LLC United States
Homecare USA, Inc. United States
Empi Corp. United States
Jan Medical, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Plasma Technologies, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at